Since 1923, we have been focused on innovation and leadership in diabetes care. Today we have a broad portfolio of medicines.
Since the launch of our first pen needle in 1985, we have been committed to enhancing injection experience by putting technology in patient hands.
Access information on our products for rare bleeding disorders, growth hormone-related disorders, and women's health.
Find information on our treatment for chronic weight management in adults who are overweight with one weight-related comorbidity or obesity.
The link above used in conjunction with the FDA-approved product labeling may be used to determine U.S. patents associated with the corresponding U.S. marketed product.
A place to find different points of view
from inside Novo Nordisk and the communities we serve.
Nicole Roberson and Gary Ault are Named Novo Nordisk Inc.’s 2020 Working Mother and Dad of the Year
Imagine what you could do with a workspace for an entire year at LabCentral, Boston’s premier, biotech-capable shared lab-facility.
For one young woman, the loss of a loved one led to a new friendship across generations
Read her story
Mary is a member of the Novo Nordisk Clinical Operations team. During the COVID-19 pandemic’s peak months in the Northeast, she returned to the bedside to care for COVID patients as a front-line nurse.
Read Mary's story
We teamed up with community partners to host a drive-through food donation event at our New Jersey headquarters
Watch video highlights
A Novo Nordisk employee reminds us that there may be more to someone’s story than we know
Read Lisa’s story
Sharing a diabetes diagnosis with his father inspires a Novo Nordisk employee to better manage his T1D
Read Ian's story
One woman’s diabetes diagnosis led to a new career, love, and mentorship for the people around her
Read Stacey’s story
A Novo Nordisk employee takes the ride of a lifetime to support diabetes research